SCHEMBL3793802

SCHEMBL3793802

O=[C]C(=O)C(=O)C(=O)c1ccc2cccc3c4cccc5cccc(c1c23)c54

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 4/20 0.40
HSD17B10 Q99714 4/20 0.40
KDM4E B2RXH2 4/20 0.40
KMT2A Q03164 4/20 0.40
HPGD P15428 3/20 0.40
GLA P06280 1/20 0.40
POLB P06746 1/20 0.40
CYP2D6 P10635 1/20 0.40
THRB P10828 1/20 0.40
ERBB2 P04626 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34
AHR P35869 1/20 0.34
WDR5 P61964 1/20 0.33
MEN1 O00255 3/20 0.33
MAPT P10636 2/20 0.33
MCL1 Q07820 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5329588 0.81 ALDH1A1 (0.45) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL3089250 0.80 ALDH1A1 (0.41) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL2023857 0.79 ALDH1A1 (0.38) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL4908831 0.78 ALDH1A1 (0.45) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL12806754 0.77 ALDH1A1 (0.52) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL3793448 0.76 NR4A1 (0.53) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL781875 0.75 HSD17B10 (0.55) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL29675165 0.75 HSD17B10 (0.55) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL28687360 0.74 HSD17B10 (0.53) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A
SCHEMBL29627281 0.74 ALDH1A1 (0.48) ALDH1A1CYP1A2HSD17B10KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378336-B2 Liquid crystalline organic semiconductor material and organic electron device FUJIFILM CORPORATION (JP) 2013-02-19 US claimed
US-20090315025-A1 LIQUID CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRON DEVICE FUJIFILM CORPORATION (JP) 2009-12-24 US claimed
EP-4210089-A1 METHOD FOR MANUFACTURING ORGANIC LAYER PATTERN, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE FUJIFILM Corporation (JP) 2023-07-12 EP disclosed
EP-4159895-A1 ELECTROFORMING METHOD AND METHOD FOR PRODUCING ELECTROFORMING MATERIAL FUJIFILM Corporation (JP) 2023-04-05 EP disclosed
US-20230101613-A1 ELECTROFORMING METHOD AND METHOD FOR PRODUCING ELECTROFORMING MATERIAL FUJIFILM CORPORATION (JP) 2023-03-30 US disclosed
US-20230092396-A1 ELECTROFORMING MASTER, METHOD FOR PRODUCING ELECTROFORMING MASTER, AND METHOD FOR PRODUCING ELECTROFORMING MATERIAL FUJIFILM CORPORATION (JP) 2023-03-23 US disclosed
EP-4151776-A1 ELECTROFORMING MASTER, METHOD FOR PRODUCING ELECTROFORMING MASTER, AND METHOD FOR PRODUCING ELECTROFORMING MATERIAL FUJIFILM Corporation (JP) 2023-03-22 EP disclosed
WO-2020195995-A1 MULTILAYER BODY, COMPOSITION, AND KIT FOR FORMING MULTILAYER BODY 富士フイルム株式会社 2020-10-01 WO disclosed
WO-2020196362-A1 MULTILAYER BODY, COMPOSITION, AND KIT FOR FORMING MULTILAYER BODY 富士フイルム株式会社 2020-10-01 WO disclosed
US-10461269-B2 Crosslinkable, /polymerizable and combinations thereof charge-transporting molecular glass mixtures, luminescent molecular glass mixtures, or combinations thereof for organic light emitting diodes and other organic electronics and photonics applications and method of making same MOLECULAR GLASSES, INC. (US) 2019-10-29 US disclosed
US-10011773-B2 Liquid crystal display device DIC CORPORATION (JP) 2018-07-03 US disclosed
US-9809752-B2 Liquid crystal display device DIC CORPORATION (JP) 2017-11-07 US disclosed
US-20170309852-A1 Light-Emitting Element, Display Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-10-26 US disclosed
US-20160215217-A1 LIQUID CRYSTAL DISPLAY DEVICE DIC CORPORATION (JP) 2016-07-28 US disclosed
US-20160130502-A1 LIQUID CRYSTAL DISPLAY DEVICE DIC CORPORATION (JP) 2016-05-12 US disclosed
US-8378336-B2 Liquid crystalline organic semiconductor material and organic electron device FUJIFILM CORPORATION (JP) 2013-02-19 US disclosed
US-20100193777-A1 METHOD OF PRODUCING A DESUBSTITUTED COMPOUND, ORGANIC SEMICONDUCTOR FILM AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION 2010-08-05 US disclosed
EP-2192631-A1 PROCESS FOR PRODUCTION OF DESUBSTITUTED COMPOUNDS, ORGANIC SEMICONDUCTOR FILM AND PROCESS FOR PRODUCTION OF THE FILM Fujifilm Corporation (JP) 2010-06-02 EP disclosed
US-20090315025-A1 LIQUID CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRON DEVICE FUJIFILM CORPORATION (JP) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090315025-A1 LIQUID CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRON DEVICE NONO, OCIAD2, PNN ALDH1A1 4796/4885CYP1A2 4287/4885HSD17B10 4742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.